Skip to main content
Logout
Boehringer Ingelheim Logo
Boehringer Ingelheim
Boehringer Ingelheim Logo
Boehringer Ingelheim
Boehringer Ingelheim Logo
Boehringer Ingelheim
  • Resources
  • Contact
  • Double Check Campaign
  • Logout

    Boehringer Ingelheim
    • Home
    • Educational Videos
    • Resources
    Home-page

    Breaking down CKD by the numbers

    CKD is a debilitating condition that often goes undiagnosed until late stages.

    upto-850
    The estimated global prevalence of CKD is >11%3 -~850 MILLION people with CKD4,5
    upto-40
    of people with T2D have CKD6,7
    upto-60
    of people with CKD have CV disease8

    Clinical Insights

    slide1

    How to detect CKD early?

    Early diagnosis of this silent disease is key. Watch the video to learn more.
    Know more
    ckd-risk-new

    What are the risk factors for CKD?

    Two simple tests can help you diagnose the disease. Watch the video to learn more.
    Know more

    One test isn’t enough

    When combined with eGFR, UACR allows healthcare professionals to stage and stratify the risk of CKD progression.

    Leading organizations suggest using 2 tests

    Using both urine albumin-to-creatinine ratio (UACR) and estimated glomerular filtration rate (eGFR) tests can help to completely screen for CKD in at-risk patients.1,2

    • Review KDIGO Opens in new tab
    • Review American Diabetes Association Opens in new tab
    leading-img
    leading-img

    EARLY TESTING CAN MEAN EARLY TREATMENT

    Detecting CKD early and starting treatment can help delay disease progression

    • Less than 20% of patients at risk for CKD between 2013 and 2019 received complete testing (defined as both eGFR and UACR) for CKD9

    • Only 10.5% of people with hypertension had complete testing9

    • SGLT2 inhibitors with documented kidney or cardiovascular benefit, ACE inhibitors, and ARBs are some of the recommended therapies for CKD10

    Why 2 tests are better than 1
    detecting-banner

    Why is it Important To Use e-GFR and UACR in Assessing CKD Patients?

    Resources

    Click to view more

    Opens in new tab
    double-check-card

    Double Check Checklist​

    • Download Opens in new tab

    References
    1. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. Kidney Int Suppl. 2024;105(4):S117-S314.

    2. American Diabetes Association Professional Practice Committee. Diabetes Care. 2024;47(Suppl. 1):S219-S230.

    3. Whelton PK, et al. Hypertension. 2018;71(6):1269-1324.

    4. ASN. The hidden epidemic: worldwide, over 850 million people suffer from kidney diseases. 2018. https://www.asn-online.org/news/2018/0626-Joint_Hidden_Epidem.pdf (accessed Mar 2023).

    5. Jager KJ, et al. Nephrol Dial Transplant. 2019;34:1803.

    6. Afkarian M, et al. JAMA. 2016;316:602.

    7. International Diabetes Foundation. Diabetes Atlas 9th Edition. http://www.diabetesatlas.org (accessed Mar 2023).

    8. Lovre D, et al. Endocrinol Metab Clin North Am. 2018;47:237.

    9. Alfego D, et al. Diabetes Care. 2021;44:2025-2032.

    10. American Diabetes Association Professional Practice Committee. Diabetes Care. 2025;48(Suppl. 1):S181-S206.

    1. Home
    2. Double Check Home
    Boehringer Ingelheim Logo
    Boehringer Ingelheim
    • Site Map
    • Privacy
    • Terms of use
    • Contact

    .

    © 2010-2023 Boehringer Ingelheim International GmbH. All rights reserved. PC-SA-102834